The phosphoramidite route has been used to prepare phospholipid analogues p
ossessing biocompatible properties and the monomer 2-(methacryloyloxy)ethyl
phosphorylcholine, utilised in the preparation of biocompatible polymers. M
odifications to established methodology include, as an alternative to the t
hermally unstable tetrazole, the use of 4,5-dichloroimidazole as an acid ca
talyst for preparing phosphite esters from the corresponding phosphoramidit
es, and the use of trimethylamine N-oxide as oxidant for the conversion of
the phosphite esters into the corresponding phosphates.